Target Name: WASHC1
NCBI ID: G100287171
Review Report on WASHC1 Target / Biomarker Content of Review Report on WASHC1 Target / Biomarker
WASHC1
Other Name(s): WASHC1 variant 1 | WAS protein family homolog 1 | WASH | FAM39E | Protein FAM39E | WASH1_HUMAN | FLJ00075 protein | WASH1 | CXYorf1-like protein on chromosome 9 | WASH complex subunit 1 | actin nucleation promoting factor | family with sequence similarity 39, member E | WASH complex subunit 1, transcript variant 1

WASHC1: A Drug Target / Disease Biomarker

WashC1 is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is a key regulator of the blood-brain barrier, which is responsible for controlling the movement of molecules into and out of the brain. WashC1 has been shown to play a role in a number of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

In addition to its role in the blood-brain barrier, WashC1 has also been shown to play a role in regulating the growth and differentiation of cells. This is important because the ability of cells to divide and differentiate is critical for the development and maintenance of tissues throughout the body.

One of the ways that WashC1 regulates cell growth and differentiation is by controlling the activity of a protein called TGF-β. TGF-β is a transcription factor that is involved in the regulation of gene expression, and it is often involved in the development and progression of cancer.

WashC1 has been shown to play a role in the regulation of TGF-β activity by interacting with its receptor, known as SMAD. This interaction between WashC1 and SMAD is important because it allows the protein to regulate the activity of TGF-β and control the growth and differentiation of cells.

Another way that WashC1 regulates cell growth and differentiation is by controlling the activity of a protein called NF-kappa-B. NF-kappa-B is a transcription factor that is involved in the regulation of inflammation and immune responses, and it is often involved in the development of neuroinflammatory diseases.

WashC1 has been shown to play a role in the regulation of NF-kappa-B activity by interacting with its receptor, known as IKK. This interaction between WashC1 and IKK is important because it allows the protein to regulate the activity of NF-kappa-B and control the production of pro-inflammatory molecules.

In addition to its role in regulating TGF-β and NF-kappa-B activity, WashC1 has also been shown to play a role in the regulation of cell adhesion. Adhesion is the process by which cells stick together to form tissues and organs, and it is important for the development and maintenance of these structures.

WashC1 has been shown to play a role in the regulation of cell adhesion by interacting with a protein called E-cadherin. E-cadherin is a transmembrane protein that is involved in the regulation of cell adhesion, and it is often involved in the development of cancer.

WashC1 is also expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys, and it is thought to play a role in the regulation of a number of important physiological processes. For example, studies have shown that WashC1 is involved in the regulation of blood-brain barrier function, and that it plays a role in the regulation of neurogenesis, the process by which new neurons are produced in the brain.

In conclusion, WashC1 is a protein that is involved in a number of important physiological processes throughout the body. Its role in the regulation of the blood-brain barrier, TGF-β, NF-kappa-B, and cell adhesion, as well as its involvement in the regulation of neurogenesis, make it an attractive target for drug development. Further research is needed to fully understand the role of WashC1 in these processes and to develop effective treatments for a variety of neurological and psychiatric disorders.

Protein Name: WASH Complex Subunit 1

Functions: Acts as a component of the WASH core complex that functions as a nucleation-promoting factor (NPF) at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization, playing a key role in the fission of tubules that serve as transport intermediates during endosome sorting (PubMed:19922874, PubMed:19922875, PubMed:20498093, PubMed:23452853). Involved in endocytic trafficking of EGF (By similarity). Involved in transferrin receptor recycling. Regulates the trafficking of endosomal alpha5beta1 integrin to the plasma membrane and involved in invasive cell migration (PubMed:22114305). In T-cells involved in endosome-to-membrane recycling of receptors including T-cell receptor (TCR), CD28 and ITGAL; proposed to be implicated in T cell proliferation and effector function. In dendritic cells involved in endosome-to-membrane recycling of major histocompatibility complex (MHC) class II probably involving retromer and subsequently allowing antigen sampling, loading and presentation during T-cell activation (By similarity). Involved in Arp2/3 complex-dependent actin assembly driving Salmonella typhimurium invasion independent of ruffling. Involved in the exocytosis of MMP14 leading to matrix remodeling during invasive migration and implicating late endosome-to-plasma membrane tubular connections and cooperation with the exocyst complex (PubMed:24344185). Involved in negative regulation of autophagy independently from its role in endosomal sorting by inhibiting BECN1 ubiquitination to inactivate PIK3C3/Vps34 activity (By similarity)

The "WASHC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WASHC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

WASHC2A | WASHC2C | WASHC3 | WASHC4 | WASHC5 | WASIR1 | WASL | WAVE1 complex | WBP1 | WBP11 | WBP11P1 | WBP1L | WBP2 | WBP2NL | WBP4 | WDCP | WDFY1 | WDFY2 | WDFY3 | WDFY3-AS2 | WDFY4 | WDHD1 | WDPCP | WDR1 | WDR11 | WDR11-DT | WDR12 | WDR13 | WDR17 | WDR18 | WDR19 | WDR20 | WDR24 | WDR25 | WDR26 | WDR27 | WDR3 | WDR31 | WDR33 | WDR35 | WDR35-DT | WDR36 | WDR37 | WDR38 | WDR4 | WDR41 | WDR43 | WDR44 | WDR45 | WDR45B | WDR46 | WDR47 | WDR48 | WDR49 | WDR5 | WDR53 | WDR54 | WDR55 | WDR59 | WDR5B | WDR6 | WDR62 | WDR64 | WDR7 | WDR70 | WDR72 | WDR73 | WDR74 | WDR75 | WDR76 | WDR77 | WDR81 | WDR82 | WDR82P1 | WDR83 | WDR83OS | WDR86 | WDR86-AS1 | WDR87 | WDR88 | WDR89 | WDR90 | WDR91 | WDR93 | WDR97 | WDSUB1 | WDTC1 | WEE1 | WEE2 | WEE2-AS1 | WFDC1 | WFDC10A | WFDC10B | WFDC11 | WFDC12 | WFDC13 | WFDC2 | WFDC21P | WFDC3 | WFDC5